The process that rebranded Albany Molecular Research Inc. as "AMRI" began about a year ago with a transtional logo. The 16-year-old Albany-based drug-discovery company had just purchased a company ...

ViralClear Pharmaceuticals Partners With Albany Molecular Research Inc. (AMRI) on the Manufacture of Merimepodib Active Pharmaceutical Ingredient in Development for the Potential Treatment of ...

Albany Molecular Research Inc. (AMRI) to Present at Jefferies 2020 Virtual London Healthcare Conference. October 14, 2020 08:00 AM Eastern Daylight Time. ALBANY, N.Y.-- ...

Fifteen months later, AMRI would announce that GTCR and a second private equity firm, The Carlyle Group of Washington, D.C., had struck an all-cash deal to acquire it for $21.75 a share, a 49 ...

ALBANY, N.Y., June 6, 2017 /PRNewswire/ -- Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences ...

Albany Molecular (AMRI) primarily produces compounds for pharmaceutical and biotechnology companies worldwide. Since the company was founded in 1991 until recently, the company has also been ...

Albany Molecular recently began talking up an aggressive growth plan to increase revenues more than 5-fold to $1.35 ... AMRI is a name worth adding to any healthcare investor's growing ...

AMRI names VP, general counsel. Feb 2, 2011 ... Albany Molecular Research Inc. has named Lori Henderson its vice president, general counsel and secretary. She will report to founder, ...

Albany Molecular Research Inc. said Tuesday it has agreed to be acquired by private-equity firms The Carlyle Group and GTCR LLC for $21.75 a share in cash, equal to a 42% premium over its 60-day ...